Aesculus Bio ApS — Credit Rating and Financial Key Figures

CVR number: 40560866
Rigensgade 11 A, 1316 København K
benjamin.jensen@sund.ku.dk
tel: 25471646

Income statement (kDKK)

2019
2020
2021
2022
2023
Fiscal period length1212121212
Net sales
Gross profit-12.17-11.7487.68-25.02-13.63
EBIT-12.17-11.7487.68-25.02-13.63
Other financial expenses-0.14-2.89-0.14-1.61-0.25
Exchange rate differences-0.617.00
Pre-tax profit-12.30-14.6386.92-19.63-13.88
Income taxes-13.385.113.00
Net earnings-12.30-14.6373.55-14.52-10.88

Assets (kDKK)

2019
2020
2021
2022
2023
Development expenditure135.27203.44203.44203.44203.44
Intangible assets total135.27203.44203.44203.44203.44
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current other receivables1.121.313.521.75
Current deferred tax assets5.1110.11
Short term receivables total1.121.318.6311.86
Cash and bank deposits2.24204.6088.3454.42
Cash and cash equivalents2.24204.6088.3454.42
Balance sheet total (assets)136.39206.98408.04300.40269.71

Equity and liabilities (kDKK)

2019
2020
2021
2022
2023
Share capital40.0040.0040.0040.0040.00
Share premium account80.0080.0080.0080.0080.00
Retained earnings-12.30-26.9446.6132.09
Profit of the financial year-12.30-14.6373.55-14.52-10.88
Shareholders equity total107.6993.06166.61152.09141.20
Non-current liabilities total
Current trade creditors7.007.0028.4517.28
Current owed to participating21.70106.92116.89116.89116.89
Short-term deferred tax liabilities13.38
Other non-interest bearing current liabilities82.7114.1411.62
Current liabilities total28.70113.92241.43148.32128.51
Balance sheet total (liabilities)136.39206.98408.04300.40269.71
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.